Corleen M. Roche insider trades
Open-market stock purchases and sales by Corleen M. Roche, Chief Financial Officer at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Apr 19, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +218%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 9, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |